AIRLINK 74.50 Decreased By ▼ -0.06 (-0.08%)
BOP 5.06 No Change ▼ 0.00 (0%)
CNERGY 4.42 Decreased By ▼ -0.04 (-0.9%)
DFML 40.50 Increased By ▲ 0.77 (1.94%)
DGKC 87.05 Decreased By ▼ -0.50 (-0.57%)
FCCL 21.87 Decreased By ▼ -0.06 (-0.27%)
FFBL 35.12 Increased By ▲ 0.53 (1.53%)
FFL 9.97 Increased By ▲ 0.22 (2.26%)
GGL 10.53 Increased By ▲ 0.04 (0.38%)
HBL 113.85 Increased By ▲ 0.06 (0.05%)
HUBC 136.03 Decreased By ▼ -0.49 (-0.36%)
HUMNL 11.90 Increased By ▲ 1.00 (9.17%)
KEL 4.83 Increased By ▲ 0.16 (3.43%)
KOSM 4.63 Decreased By ▼ -0.01 (-0.22%)
MLCF 38.35 Decreased By ▼ -0.11 (-0.29%)
OGDC 136.65 Increased By ▲ 0.51 (0.37%)
PAEL 26.95 Increased By ▲ 0.34 (1.28%)
PIAA 20.80 Decreased By ▼ -1.69 (-7.51%)
PIBTL 6.76 Increased By ▲ 0.09 (1.35%)
PPL 123.30 Increased By ▲ 1.01 (0.83%)
PRL 27.08 Increased By ▲ 0.11 (0.41%)
PTC 14.46 Increased By ▲ 0.55 (3.95%)
SEARL 60.60 Increased By ▲ 0.73 (1.22%)
SNGP 70.20 Increased By ▲ 0.14 (0.2%)
SSGC 10.38 Increased By ▲ 0.03 (0.29%)
TELE 8.55 Increased By ▲ 0.01 (0.12%)
TPLP 11.25 Decreased By ▼ -0.09 (-0.79%)
TRG 65.40 Decreased By ▼ -0.60 (-0.91%)
UNITY 26.35 Increased By ▲ 0.02 (0.08%)
WTL 1.34 Decreased By ▼ -0.01 (-0.74%)
BR100 7,846 Increased By 21.5 (0.28%)
BR30 25,482 Increased By 76.6 (0.3%)
KSE100 75,261 Increased By 177.3 (0.24%)
KSE30 24,130 Increased By 36.6 (0.15%)

Pfizer Inc

Indian shares rise
Markets

Indian shares rise

BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Published 09 Nov, 2021 04:48am
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion
Business & Finance

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Published 04 May, 2021 07:48pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm